[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.157.225.99. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,082
Citations 0
Comment & Response
July 16, 2014

Interpreting Whole-Genome Sequencing

Author Affiliations
  • 1Clinical Genomics Center, UCLA School of Medicine, Los Angeles, California
JAMA. 2014;312(3):296. doi:10.1001/jama.2014.6602

To the Editor We believe that the report of the yield and interpretability of clinical whole-genome sequencing by Dr Dewey and colleagues1 is unduly pessimistic about the present and future efficacy of this molecular genetic technology in clinical medicine. Their experience of low coverage of key disease genes, poor nucleotide-calling reproducibility, low diagnostic yield, and insurmountable interpretative challenges for unexpected variants is at odds with that of most centers offering clinical genomic sequencing,2 including our own.

First Page Preview View Large
First page PDF preview
First page PDF preview
×